{
    "clinical_study": {
        "@rank": "106059", 
        "arm_group": [
            {
                "arm_group_label": "Healthy controls", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Cirrhosis", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The study investigates the effect of aminoacid infusion on proteinturnover in muscle from\n      cirrhosis subjects, compared to healthy controls.\n\n      The hypothesis is that aminoacid infusion can attenuate the increase in proteindegradation\n      that follows cirrhosis."
        }, 
        "brief_title": "Sarcopenia and Cirrhosis", 
        "condition": "Cirrhosis", 
        "condition_browse": {
            "mesh_term": [
                "Liver Cirrhosis", 
                "Fibrosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male subjects\n\n          -  Diagnosis of cirrhosis, Child-Pugh A, B, C.\n\n        Exclusion Criteria:\n\n          -  Acute illness within 3 weeks\n\n          -  Ascites collections within 10 days\n\n          -  Heart-, kidney, pulmonary disease. Cancer. Type 1 diabetes.\n\n          -  Active alkoholdrinking"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 30, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02132962", 
            "org_study_id": "H-4-2012-162"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Healthy controls", 
                    "Cirrhosis"
                ], 
                "intervention_name": "Amino acid infusion", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": [
                    "Healthy controls", 
                    "Cirrhosis"
                ], 
                "intervention_name": "Bloodsamples, Biopsies.", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 12, 2014", 
        "location": {
            "contact": {
                "email": "rinnov@gmail.com", 
                "last_name": "Anders R Rinnov, MD, PhD", 
                "phone": "+4535458609"
            }, 
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "zip": "2100"
                }, 
                "name": "Rigshospitalet"
            }, 
            "investigator": {
                "last_name": "Anders R Rinnov, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "rinnov@gmail.com", 
            "last_name": "Anders R Rinnov, MD, PhD", 
            "phone": "+4535458609"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Dataprotection Agency"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Using stable isotope tracer technique with infusion of phenylalanine and tyrosine tracer.\nUsing ELISA technique. Using PCR and western blot technique.", 
            "measure": "Turnover of phenylalanine and tyrosine in skeletal muscle tissue during amino acid infusion. Inflammatory markers. Protein signaling cascade.", 
            "safety_issue": "No", 
            "time_frame": "24 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02132962"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rigshospitalet, Denmark", 
            "investigator_full_name": "Anders Rasmussen Rinnov", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Rigshospitalet, Denmark", 
        "sponsors": {
            "collaborator": {
                "agency": "Hvidovre University Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Rigshospitalet, Denmark", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}